Premier Path Wealth Partners, LLC
Position in AMLX — Amylyx Pharmaceuticals, Inc.
CIK 1999925
MADISON, NJ
Position in AMLX
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$328,039
+$46,356 QoQ
Shares Held
18,265
-9.9% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#131
of 207 holders
Holding Since
Dec 2023
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Premier Path Wealth Partners, LLC holds $704,010 across 2 Drug Manufacturers - Specialty & Generic names. AMLX ranks #2 (46.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
5,232 | $375,971 | |
| 2 | AMLX |
Amylyx Pharmaceuticals, Inc.
This page
|
18,265 | $328,039 |
All Filings in AMLX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $328,039 | 18,265 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $281,683 | 20,265 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $244,801 | 20,265 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $275,401 | 20,265 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $129,898 | 20,265 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $71,738 | 20,265 | Shares | Sole | 2025-04-21 | |
| 2024-09-30 | $65,658 | 20,265 | Shares | Sole | 2024-10-15 | |
| 2024-03-31 | $57,552 | 20,265 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $298,300 | 20,265 | Shares | Sole | 2024-01-12 | |
| No filing history on record for this holder in this stock. | ||||||